Capital International Investors
TEVA icon

Capital International Investors’s Teva Pharmaceuticals TEVA Stock Holding History

Capital International Investors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.2M Buy
2,838,031
+14,757
+0.5% +$492K 0.02% 292
2026
Q1 		$85M Buy
2,823,274
+28,490
+1% +$917K 0.02% 298
2025
Q4 		$87.2M Buy
2,794,784
+66,830
+2% +$1.65M 0.01% 311
2025
Q3 		$55.1M Buy
2,727,954
+18,966
+0.7% +$333K 0.01% 337
2025
Q2 		$45.4M Buy
2,708,988
+7,927
+0.3% +$128K 0.01% 337
2025
Q1 		$41.5M Buy
2,701,061
+36,268
+1% +$648K 0.01% 336
2024
Q4 		$58.7M Sell
2,664,793
-515,348
-16% -$9.38M 0.01% 327
2024
Q3 		$57.3M Sell
3,180,141
-1,332
-0% -$23.3K 0.01% 313
2024
Q2 		$51.7M Sell
3,181,473
-4,246
-0.1% -$65.4K 0.01% 312
2024
Q1 		$45M Sell
3,185,719
-6,791,762
-68% -$85.6M 0.01% 331
2023
Q4 		$104M Sell
9,977,481
-7
-0% -$65 0.02% 278
2023
Q3 		$102M Sell
9,977,488
-5,340
-0.1% -$49.7K 0.03% 273
2023
Q2 		$75.2M Hold
9,982,828
– – 0.02% 308
2023
Q1 		$88.3M Sell
9,982,828
-694,512
-7% -$6.87M 0.02% 298
2022
Q4 		$97.4M Buy
10,677,340
+2,109
+0% +$18.4K 0.03% 288
2022
Q3 		$86.1M Sell
10,675,231
-7,647
-0.1% -$67.6K 0.03% 307
2022
Q2 		$80.3M Buy
10,682,878
+697,911
+7% +$6.08M 0.02% 313
2022
Q1 		$93.8M Sell
9,984,967
-7,644
-0.1% -$63.8K 0.02% 318
2021
Q4 		$80M Sell
9,992,611
-8,924
-0.1% -$80.5K 0.02% 333
2021
Q3 		$97.4M Buy
10,001,535
+2,833
+0% +$26.5K 0.02% 301
2021
Q2 		$99M Sell
9,998,702
-4,613,466
-32% -$48.8M 0.02% 301
2021
Q1 		$169M Sell
14,612,168
-11,923,262
-45% -$137M 0.04% 245
2020
Q4 		$256M Buy
26,535,430
+3,121,721
+13% +$29.9M 0.07% 213
2020
Q3 		$211M Buy
23,413,709
+2,904,751
+14% +$30.7M 0.07% 218
2020
Q2 		$253M Buy
20,508,958
+6,627,062
+48% +$74.9M 0.08% 187
2020
Q1 		$125M Buy
+13,881,896
New +$142M 0.05% 205
2017
Q2 		– Sell
-711,844
Closed -$22.8M – 253
2017
Q1 		$22.8M Buy
711,844
+386
+0.1% +$13.2K 0.03% 222
2016
Q4 		$25.8M Sell
711,458
-708
-0.1% -$28.3K 0.04% 214
2016
Q3 		$32.8M Buy
712,166
+2,166
+0.3% +$113K 0.05% 218
2016
Q2 		$35.7M Hold
710,000
– – 0.05% 211
2016
Q1 		$38M Hold
710,000
– – 0.06% 208
2015
Q4 		$46.6M Hold
710,000
– – 0.07% 205
2015
Q3 		$40.1M Hold
710,000
– – 0.07% 201
2015
Q2 		$42M Hold
710,000
– – 0.07% 200
2015
Q1 		$44.2M Hold
710,000
– – 0.08% 194
2014
Q4 		$40.8M Hold
710,000
– – 0.08% 190
2014
Q3 		$38.2M Hold
710,000
– – 0.09% 174
2014
Q2 		$37.2M Hold
710,000
– – 0.1% 171
2014
Q1 		$37.5M Hold
710,000
– – 0.1% 171
2013
Q4 		$28.5M Hold
710,000
– – 0.09% 174
2013
Q3 		$26.8M Hold
710,000
– – 0.11% 161
2013
Q2 		$27.8M Buy
+710,000
New +$27.6M 0.13% 147

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors's TEVA Position: Q2 2026 in Review

Capital International Investors increased its Teva Pharmaceuticals (TEVA) stake by 0.52% in Q2 2026, buying an estimated $492K and bringing the position to 2,838,031 shares worth $96.2M. The position accounts for 0.02% of the portfolio, ranked #292.

Capital International Investors first reported a position in TEVA in Q2 2013 and has held it in 42 quarters since. The position peaked at $256M in Q4 2020. 523 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Capital International Investors held 2,838,031 shares of Teva Pharmaceuticals worth $96.2M as of Q2 2026.
  • Capital International Investors bought 14,757 Teva Pharmaceuticals shares in Q2 2026, an estimated $492K.
  • Teva Pharmaceuticals made up 0.02% of Capital International Investors's portfolio in Q2 2026, its #292 holding.
  • Capital International Investors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 42 quarters since.
  • Capital International Investors's Teva Pharmaceuticals position peaked at $256M in Q4 2020.
  • 523 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Capital International Investors's 13F filing for Q2 2026, filed 12 Aug 2026.